Objectives: Hyperhomocyst(e)inemia is a risk factor for atherosclerotic vascular disease, and it is associated with endothelial dysfunction. Mechanisms responsible for endothelial dysfunction in hyperhomocyst(e)inemia may involve impaired bioavailability of NO, possibly secondary to accumulation of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) and increased oxidative stress. We investigated whether oral treatment with B vitamins or L-arginine normalizes endothelium-dependent, flow-dependent vasodilation (FDD) in patients with peripheral arterial occlusive disease (PAOD) and hyperhomocyst(e)inemia. Methods: 27 patients with PAOD and hyperhomocyst(e)inemia were assigned to oral treatment with combined B vitamins (folate, 10 mg; vitamin B-12, 200 mg; vitamin B-6, 20 mg / day), L-arginine (24 g / day) or placebo, for 8 weeks in a double-blind fashion. FDD was determined by high-resolution ultrasound in the radial artery. Results: Vitamin B supplementation significantly lowered plasma homocyst(e)ine concentration from 15.861.8 to 8.761.1 mmol / l (P,0.01). However, B vitamins had no significant effect on FDD (baseline, 7.860.7%, B vitamins, 8.360.9%, placebo 8.960.7%; P5n.s.). In contrast, L-arginine treatment did not affect homocyst(e)ine levels, but significantly improved FDD (10.260.2%), probably by antagonizing the impact of elevated ADMA concentration (3.860.3 mmol / l) and reducing the oxidative stress by lowering urinary 8-iso-prostaglandin F (baseline, 76.367.1 vs. 62.768.3 pmol / mmol creatinine after 8 weeks). Conclusions: Oral supplementation with combined B vitamins during 8 weeks does not improve endothelium-dependent vasodilation in PAOD patients with hyperhomocyst(e)inemia, whereas L-arginine significantly improved endothelial function in these patients. Thus, accumulation of ADMA and increased oxidative stress may underlie endothelial dysfunction under hyperhomocyst(e)inemic conditions. These findings may have importance for evaluation of homocyst(e)ine-lowering therapy.
. Introduction
peripheral arterial occlusive disease (PAOD), and it is associated with progression of the disease [4, 5] . HyperElevated homocyst(e)ine concentrations have been idenhomocyst(e)inemia may be due to inherited enzyme detified as an independent cardiovascular risk factor [1] [2] [3] .
fects, renal insufficiency, or inherited or acquired defects Hyperhomocyst(e)inemia is common in patients with in homocysteine metabolism [6] . B vitamins are essential cofactors for the transsulfuration of homocysteine to cystathionine by cystathionine b-synthase (vitamin B-6),
q The term 'hyperhomocyst(e)inemia' is used in this paper to indicate and the remethylation of homocysteine to methionine by that plasma homocysteine assays measure the total concentration of thiol, methionine synthase (folic acid, vitamin B-12 with combined B vitamins is an efficient means to decrease tion of acetylsalicylic acid, all medication was stopped 24 h plasma homocyst(e)ine [7] . However, the results of prosbefore measurements. None of the participants were taking pective studies investigating potential beneficial effects of additional vitamin supplements as assessed at the baseline. B vitamin supplementation on vascular function in patients They were all advised not to start vitamin supplementation with PAOD and hyperhomocyst(e)inemia are lacking [3] .
while the study was ongoing. Alcohol and caffeine were The mechanism(s) by which homocysteine contributes to prohibited within 12 h of the study. At baseline, a venous vascular disease remain poorly understood. Homocysteine blood sample was taken under fasting conditions for the alters the normal antithrombotic properties of the vascular measurement of plasma total homocyst(e)ine, B vitamin, wall by modulating the activity of the coagulant and L-arginine, ADMA and symmetric dimethylarginine fibrinolytic systems, and promotes vascular smooth muscle (SDMA) levels. A urine sample was collected to measure cell proliferation [8] . Furthermore, there is evidence that urinary excretion of 8-iso-PGF . Endothelium-dependent 2a hyperhomocyst(e)inemia is associated with endothelial and -independent vasodilation was determined in the radial dysfunction in animals and humans [9] [10] [11] . Mechanisms artery of the non-dominant arm using a highly sensitive may involve reduced elaboration of NO by the endoand specific ultrasonic method as described below. thelium or oxidative inactivation of NO. Homocysteine Baseline data on flow-mediated vasodilation were also increases the oxidative degradation of NO through the obtained in a group of 12 age-matched healthy controls formation of disulfides and the generation of hydrogen (eight men; age, 73.460.7 years). Systolic ankle pressures peroxide and superoxide anion [12, 13] . In a recent study were measured by Doppler in the dorsal foot artery and the we found that cynomolgus monkeys fed a methionine-rich posterior tibial artery. Systolic and diastolic arterial blood diet showed elevated plasma levels of asymmetric dipressure was measured at the ipsilateral arm with the methylarginine (ADMA) [14] , an endogenous NO synthase standard sphygmomanometric method. Patients were raninhibitor [15] . Lowering homocysteine levels with B domized to receive either a mixture of B vitamins folic vitamins in these animals did not improve endothelial acid (10 mg / day), vitamin B-6 (pyridoxal 59-phosphate, function, which was closely correlated to ADMA plasma 20 mg / day), vitamin B-12 (cyanocobalamin, 200 mg / day), concentration [14] . Furthermore, a methyl group which is L-arginine (24 g / day), or placebo, in three daily doses, for cleaved during synthesis of homocysteine from methionine 8 weeks in a double-blind fashion. Randomization and is utilized during ADMA synthesis in cultured human labelling of the visually identical medication vials was endothelial cells, thereby linking homocysteine and performed by the local pharmacy, and the randomization ADMA metabolic pathways [16] .
code was strictly concealed from the investigators until the In the present study we investigated whether suppleend of the study. After 4 and 8 weeks of treatment mentation with folic acid, vitamin B-12, and vitamin B-6 additional sets of blood and urine samples were collected, reduces elevated homocyst(e)ine plasma levels and imand blood pressure measurements, and endothelial function proves endothelium-dependent, NO-mediated vasodilation study were repeated. One patient in each group withdrew and vascular functional status in PAOD patients. We also consent to participate after the baseline visit. The instudied whether ADMA concentration and urinary excrevestigation conforms with the principles outlined in the tion of 8-iso-prostaglandin-F (8-iso-PGF )-a nonDeclaration of Helsinki. The study protocol had previously 2a 2a
invasive marker for oxidative stress in vivo-are elevated, been approved by the Institutional Review Board for and whether oral L-arginine supplementation improves Studies in Humans at Hannover Medical School. Characendothelial function in these patients. Improved endothelial teristics of the patients are shown in Table 1 . function is associated with reduced progression of cardiovascular disease [17] , and may therefore indicate an overall beneficial effect of these treatments on athero-2 .2. Endothelium-dependent and -independent sclerosis in patients with cardiovascular disease and high vasodilation homocyst(e)ine plasma levels.
Radial artery diameters were measured after an overnight fasting period by a high-resolution A-mode ul-2 . Methods trasonic echo-tracking device (ASULAB) by a 10 MHz transducer that allows measurements of arterial diameter 2 .1. Patients and study protocol with a precision of 62.5 mm [18] . Forearm blood flow was measured continuously by an 8-MHz Doppler probe Twenty-seven patients with PAOD and stable intermit-(Vasoscope III) 5 cm proximal to the 10-MHz probe. tent claudication who had elevated homocyst(e)ine plasma Arterial blood flow (ml / min) at the mid-forearm level was concentration gave their written informed consent to calculated as the product of blood flow velocity and crossparticipate in the study. All patients had been on a stable sectional area. Wrist arterial occlusion was performed by medication before the beginning of the study, and doses inflating an occlusion cuff to 40 mmHg above systolic remained unchanged throughout the study. With the excepblood pressure for 8 min. After release of arterial occlu- was determined from a morning urine sample by gas chromatography-tandem mass spectrometry [24] .
Occlusion type (n) Iliaco-femoral 4 6 4 Plasma total cholesterol and triglyceride concentrations Multisegmental 5 3 5 were determined spectrophotometrically using standard laboratory methods.
Cardiovascular risk factors (n) Hypercholesterolemia 6 5 4 Based on previous studies [10, 11] , we calculated that a sample size of at least eight patients per group was needed Data are mean6S.E.M. or number of patients (N) as indicated. There were no significant differences between the groups in any of the to detect a 2.5% increase in endothelium-dependent vasoparameters.
.4. Calculations and statistical analyses
dilation with an estimated S.D. of 1.5% [11] with 90% power and a significance level of 0.05. Nine patients were sion, arterial diameter was determined until diameter included in each treatment group; after drop-outs, complete returned to baseline. Maximal flow-mediated vasodilation data sets were available for eight patients per group which was used for further data analysis; it occurred at 6264 s.
were analyzed on an on-treatment basis. Data are given as After measurement of flow-dependent vasodilation, 30 min mean6S.E.M. Statistical significance was tested using of rest was allowed. Thereafter, endothelium-independent analysis of variance (ANOVA) for repeated measurements vasodilation was assessed as the vasodilator response to using the Bonferroni-Dunn correction. Statistical signifisublingual nitroglycerine (0.4 mg). Maximal vasodilation cance was accepted for P,0.05. to nitroglycerine occurred at 4.260.7 min; this value was used in statistical data analysis. Reproducibility and variability of the method were very good as previously 3 . Results determined in our laboratory [19] .
3 .1. Endothelial function
.3. Biochemical analyses
Baseline diameter of the radial artery was 3.03960.084 mm in the B vitamin group, 3.14560.088 mm in the Blood samples were obtained after an overnight fasting L-arginine group, and 3.21460.105 mm in the placebo period and were drawn into pre-chilled vacutainers congroup (P5n.s. between groups). After 8 weeks, there was taining EDTA, and immediately centrifuged. Plasma was no significant difference in baseline arterial diameter in stored at 220 8C in appropriate aliquots until analyses.
either of the groups (B vitamins, 3.08460.084 mm; LFasting plasma homocyst(e)ine concentrations were arginine, 3.08960.096 mm; placebo, 3.19460 .106 mm; measured by high-performance liquid chromatography P5n.s.). Intraday variability of the measurements was based upon the modification described by Ubbink et al.
0.460.2% at the baseline visit and 0.460.1% at 8 weeks. [20] of the method of Araki and Sako [21] . Briefly, plasma Reproducibility of diameter measurements between or standards were incubated with tri-n-butylphosphine in baseline and week 8 was 1.1960.46%. dimethylformamide (10% v / v) for 30 min (4 8C) to Mean flow-induced, NO-mediated vasodilation of the accomplish reduction of homocyst(e)ine and its release radial artery was 7.660.5% at baseline with no significant from protein binding. Subsequently, protein was precipidifference between the groups, as compared to 12.360.9% tated with trichloroacetic acid. After centrifugation, the in age-matched healthy controls (P,0.05; Fig. 1 (Table  3) . study period in each of the three treatment groups (Table  Plasma concentrations of ADMA were significantly  2) .
elevated as compared to levels reported for healthy subjects of the same age (3.860.3 mmol / l vs. 1.060.1 mmol / l) [25] . None of the treatments exerted a significant effect 3 .2. Biochemical assays on ADMA or SDMA concentrations ( Table 3 ). The mean L-arginine levels of the three groups were 43.163.0 mmol / Plasma total homocyst(e)ine levels at baseline were l at baseline. They increased to 70.9612.6 mmol / l during 15.061.4 mmol / l (mean6S.E.M.) with no significant L-arginine supplementation (P,0.05), and were unchanged difference between the groups. After treatment with B in the other two groups (Table 3) . L-Arginine /ADMA ratio vitamins for 8 weeks, plasma homocyst(e)ine concentration was significantly increased by L-arginine supplementation, was significantly decreased to 8.761.1 mmol / l (P,0.01; but unaffected in the other groups (Fig. 3) . Fig. 2 ). Neither L-arginine nor placebo had a significant Urinary excretion of 8-iso-PGF was 73.865.5 pmol / 2a effect on homocyst(e)ine levels (Fig. 2) . mmol creatinine at baseline. It was significantly reduced Plasma concentrations of vitamins B-6, B-12, and folic during L-arginine treatment (62.768.3 pmol / mmol creatinine), but remained unchanged in the B vitamin and placebo groups (Fig. 4) .
.3. Functional status
None of the treatments had a significant effect on systemic blood pressure, systolic ankle blood pressure, or ankle-brachial pressure index (Table 2 ).
. Discussion
The present data indicate that supplementation with folic acid and vitamins B-12 and B-6 during 8 weeks does not improve endothelium-dependent vasodilation in PAOD patients despite a significant reduction in plasma homocyst(e)ine concentration. By contrast, supplementation with L-arginine, which does not affect homocyst(e)ine plasma High plasma homocyst(e)ine concentrations have been associated with increased risk of cardiovascular disease [2] . The implicit notion from these studies has been that lowering plasma homocyst(e)ine levels with pharmacotherapeutic measures may decrease the risk of cardiovascular disease, although several authors have emphasized the need for careful scrutiny of this inference in appropriate controlled clinical trials.
Hyperhomocyst(e)inemia is due to vitamin deficiency in many healthy elderly subjects and in many PAOD patients [4] . An increased risk of cardiovascular disease progression may even be inferred from vitamin plasma levels within the normal range. In the present study baseline plasma concentrations of folic acid, vitamin B-12, and vitamin B-6 were above the lower limit of the recommended plasma homocyst(e)ine levels, which is in accordance with previaction of folic acid as a precursor for tetrahydrobiopterin, ous data [7, 26] .
an essential cofactor of endothelial NO synthase, might be One mechanism by which homocysteine may affect responsible for the beneficial effect on endothelium-depenphysiological function of the vascular wall is reducing the dent vasodilation [31, 32] . Indeed, infusion of tetrahydrobiological activity of NO. The mechanism of this interbiopterin has been shown to improve endothelial function action between homocysteine and NO may be multifactoriin subjects with familial hypercholesterolemia in the al [12] [13] [14] . Lentz et al. found that monkeys fed a diet absence of hyperhomocyst(e)inemia [32] . enriched in methionine and deficient in folate and choline Our data show no improvement of flow-dependent exhibited impaired endothelium-dependent vasodilation in vasodilation despite a significant reduction of homocyvivo and ex vivo [9] . In two more recent studies, Tawakol st(e)ine levels by about 50% after B vitamin treatment in et al. [10] and Woo et al. [11] found that humans with patients with PAOD and hyperhomocyst(e)inemia. This moderate hyperhomocyst(e)inemia also displayed impaired observation was made despite the facts that (1) measureendothelium-dependent vasodilation. Flow-induced vasodiments were performed in the radial artery where no lation in the brachial artery was significantly impaired in atherosclerotic plaques are present even in PAOD patients. patients as compared to controls.
Radial artery endothelium-dependent vasodilation is reFrom these studies, it was tempting to speculate that sponsive to pharmacological intervention, as indicated by lowering of plasma homocyst(e)ine levels by dietary the improvement that can be obtained with vitamin C supplementation with B vitamins may improve endothelial treatment [19] and with L-arginine as evidenced by the function. However, significant doubt has been shed on this results of the present study; (2) dosage of B vitamins was concept by a recent study in nonhuman primates in which sufficient and compliance of the patients was good, as Lentz et al. [27] observed that dietary supplementation assessed by individual plasma homocyst(e)ine and B with B vitamins did not reverse a pre-existing dysfunction vitamin levels after treatment; (3) the study had sufficient in endothelium-dependent vasodilation in monkeys with statistical power to detect even a small (2.5%) increase in diet-induced hyperhomocyst(e)inemia and hypercholesendothelium-dependent vasodilation, as evidenced also by terolemia. These investigators found no improvement of the significant improvement in the L-arginine group; and endothelium-dependent vasodilation in resistance vessels (4) the method of ultrasonic echo-tracking of the vascular in vivo and in the carotid artery ex vivo, even after a wall that we applied is extremely sensitive and has an period of 17 months of B vitamin supplementation in excellent reproducibility and variability as previously monkeys fed an atherogenic diet that produces both shown by two of us (BH, NA) [19] . Flow-dependent hyperhomocyst(e)inemia and hypercholesterolemia. Furvasodilation determined by this method has been found to thermore, the anticoagulant responses of thrombin infusion be largely dependent upon endothelial NO release, as were also impaired and B vitamins failed to prevent indicated by the inhibitory effect of N-monomethyl-Lintimal thickening in the carotid or iliac arteries [27] . Even arginine (L-NMMA) [19] . in healthy human subjects with acute elevation of homo-
The detrimental effect of homocysteine on endothelial cyst(e)ine by oral methionine loading, the synthesis of function may be indirect in nature. We previously reported ADMA was stimulated due to a transmethylation reaction that plasma levels of the endogenous NO synthase inhibwhich occurs during formation of homocyst(e)ine from itor ADMA are increased in hyperhomocyst(e)inemic methionine [28] . After methionine bolus, elevation of monkeys [14] . Recently, we have shown that a radioactivehomocyst(e)ine was associated with increased plasma ly labeled methyl group from S-adenosylmethionine-an concentration of ADMA, and reduced flow-mediated vasointermediate during the formation of homocysteine from dilation. There was a significant inverse linear relationship methionine-is transferred to arginine to yield ADMA by between ADMA concentration and flow-mediated vasodiprotein arginine N-methyltransferases in cultured human lation, which was stronger than the relation between endothelial cells [16] . Thus, endothelial dysfunction in homocyst(e)ine concentration and flow-mediated vasodilathyperhomocyst(e)inemia may be secondary to elevated ion. The results are, however, in contrast to recent studies ADMA levels and reduced endothelial NO synthase activiin humans [29, 30] . Title et al. found an improvement of ty (Fig. 5) . We have recently identified ADMA as an endothelium-dependent flow-mediated dilation in 25 paindependent cardiovascular risk factor in a prospective tients with coronary artery disease after supplementation clinical trial [33] . Pursuing this hypothesis further, we with folic acid for 4 months [29] . However, there was no investigated whether supplementation with L-arginine impositive effect of a combination with folic acid and proves endothelial dysfunction in our patients. L-Arginine antioxidants. Usui et al. showed that high dose folic acid has previously been shown to reverse the detrimental supplementation improved endothelium-dependent vasodieffects of high ADMA levels on endothelial function in lation in humans after an acute methionine load [30] . In hypercholesterolemic subjects [23] . Indeed, L-arginine this study folic acid did not lower homocyst(e)ine consignificantly improved endothelium-dependent vasodilation centration, which led these authors to conclude that the without affecting homocyst(e)ine levels. L-Arginine / hypercholesterolemia, diabetes, smoking, and even in patients with acute myocardial infarction and unstable coronary disease [40] [41] [42] [43] . We found that urinary excretion of 8-iso-PGF , a marker of lipid peroxidation in vivo, was 2a increased in this population at baseline. Interestingly, B vitamin treatment did not significantly affect 8-iso-PGF 2a excretion, whereas L-arginine supplementation reduced this biomarker. Inhibition of NO synthase by ADMA increases vascular oxidative stress, which results in enhanced monocyte adhesion [44] . This effect is reversed by L-arginine and may explain the antioxidative actions of this amino acid that have previously been reported [45] . Kanani et al. showed that oxidative stress is involved in the endothelial dysfunction associated with acute hyperhomocyst(e)inemia after oral methionine loading [46] . We recently demon- homocysteine on endothelial function may be indirect in nature, due to elevation of the endogenous NO synthase ADMA ratio was increased by about twofold during L- inhibitor ADMA, and antagonized by supplementation arginine supplementation, which may indicate enhanced with L-arginine. The results of randomized, large-scale substrate availability for NO synthase.
clinical intervention trials need to be awaited and carefully There is evidence that increased oxidative stress acscrutinized to definitely confirm or exclude a potential counts for a significant proportion of endothelial dysfuncbenefit of folic acid, vitamin B-12, and vitamin B-6 on tion. Increased production of oxygen-derived free radicals incidence or progression of cardiovascular disease. Fursuch as superoxide anion has been linked to impaired thermore, other therapeutic interventions with lipid-lowerendothelial vasomotor function in experimental models of ing drugs, ACE inhibitors, and antioxidant agents seem to atherosclerosis [34, 35] . Recently, Heitzer et al. could show be an interesting tool to improve endothelial function in that endothelial dysfunction and increased vascular oxidacoronary and peripheral vessels in patients with hypertive stress are predictors for the risk of cardiovascular homocyst(e)inemia. events in patients with coronary artery disease [36] . Endothelial dysfunction in hyperhomocyst(e)inemia has been partly explained by increased oxidative stress [12, 13] .
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